Therapeutic Approaches for Peripheral and Central Neuropathic Pain

被引:119
|
作者
Szok, Delia [1 ]
Tajti, Janos [1 ]
Nyari, Aliz [1 ]
Vecsei, Laszlo [1 ,2 ]
机构
[1] Univ Szeged, Fac Med, Interdisciplinary Excellence Ctr, Dept Neurol, Semmelweis U 6, H-6725 Szeged, Hungary
[2] MTA SZTE Neurosci Res Grp, Semmelweis U 6, H-6725 Szeged, Hungary
关键词
TRAUMATIC BRAIN-INJURY; NERVE FIELD STIMULATION; DORSAL-ROOT GANGLION; PHARMACOLOGICAL MANAGEMENT; NEUROSTIMULATION THERAPY; TRIGEMINAL NEURALGIA; IASP CLASSIFICATION; POSTSURGICAL PAIN; BACK-PAIN; THORACOTOMY;
D O I
10.1155/2019/8685954
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Neuropathic pain is a chronic secondary pain condition, which is a consequence of peripheral or central nervous (somatosensory) system lesions or diseases. It is a devastating condition, which affects around 7% of the general population. Numerous etiological factors contribute to the development of chronic neuropathic pain. It can originate from the peripheral part of the nervous system such as in the case of trigeminal or postherpetic neuralgia, peripheral nerve injury, painful polyneuropathies, or radiculopathies. Central chronic neuropathic pain can develop as a result of spinal cord or brain injury, stroke, or multiple sclerosis. As first-line pharmacological treatment options, tricyclic antidepressants, serotonin-norepinephrine reuptake inhibitors, and gabapentinoids are recommended. In trigeminal neuralgia, carbamazepine and oxcarbazepine are the first-choice drugs. In drug-refractory cases, interventional, physical, and psychological therapies are available. This review was structured based on a PubMed search of papers published in the field from 2010 until May 2019.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Therapeutic options for neuropathic pain
    King, John C.
    JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2007, 62 (06): : S7 - S7
  • [42] Spinal cord injury induced neuropathic pain: Molecular targets and therapeutic approaches
    Dominic Schomberg
    Gurwattan Miranpuri
    Tyler Duellman
    Andrew Crowell
    Raghu Vemuganti
    Daniel Resnick
    Metabolic Brain Disease, 2015, 30 : 645 - 658
  • [43] A novel therapeutic strategy for neuropathic pain through regulating peripheral immune cells
    Kobayashi, Yuka
    Kiguchi, Norikazu
    Fukazawa, Yohji
    Saika, Fumihiro
    Maeda, Takehiko
    Kishioka, Shiroh
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2015, 128 (03) : S69 - S69
  • [44] Therapeutic Targets for the Management of Peripheral Nerve Injury-Induced Neuropathic Pain
    Jaggi, Amteshwar Singh
    Singh, Nirmal
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2011, 10 (05) : 589 - 609
  • [45] Spinal cord injury induced neuropathic pain: Molecular targets and therapeutic approaches
    Schomberg, Dominic
    Miranpuri, Gurwattan
    Duellman, Tyler
    Crowell, Andrew
    Vemuganti, Raghu
    Resnick, Daniel
    METABOLIC BRAIN DISEASE, 2015, 30 (03) : 645 - 658
  • [46] Therapeutic drugs for neuropathic pain
    Tewari, R
    Boswell, MV
    Rosenberg, SK
    JOURNAL OF BACK AND MUSCULOSKELETAL REHABILITATION, 1997, 9 (03) : 247 - 254
  • [47] PERIPHERAL AND CENTRAL SENSITIZATION AND NEUROPATHIC PAIN ARE PRESENT IN BOTH OSTEOARTHRITIS AND RHEUMATOID ARTHRITIS
    Chua, J.
    Ishihara, S.
    Riad, M.
    Castrejon, I.
    Miller, R.
    Malfait, A. -M.
    Block, J.
    Shakoor, N.
    OSTEOARTHRITIS AND CARTILAGE, 2019, 27 : S414 - S414
  • [48] EFFECTS OF TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION IN PATIENTS WITH PERIPHERAL AND CENTRAL NEUROPATHIC PAIN
    Kilinc, Muhammed
    Livanelioglu, Ayse
    Yildirim, Sibel Aksu
    Tan, Ersin
    JOURNAL OF REHABILITATION MEDICINE, 2014, 46 (05) : 454 - 460
  • [49] The effect of ketamine on phantom pain: A central neuropathic disorder maintained by peripheral input
    Nikolajsen, L
    Hansen, CL
    Nielsen, J
    Keller, J
    ArendtNielsen, L
    Jensen, TS
    PAIN, 1996, 67 (01) : 69 - 77
  • [50] Peripheral immune contributions to the maintenance of central glial activation underlying neuropathic pain
    Grace, Peter M.
    Rolan, Paul E.
    Hutchinson, Mark R.
    BRAIN BEHAVIOR AND IMMUNITY, 2011, 25 (07) : 1322 - 1332